fluoride varnish 22600ppm
Small molecule
fluoride varnish 22600ppm is one of 10 small molecule programs targeting Dental Caries. It is currently in development.
1
Indications
1
Total Trials
0
Active Trials
9
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
15 competitors in Dental Caries
#DrugCompanyPhaseTrials
1Betadine
BBecton, Dickinson and Company
Approved
Zocor
OOrganon and Co
Approved
Peridex
DDexcel Pharma Technologies Ltd.
Approved
Mycostatin
GGood Molecules, LLC
Approved
Peridex
MMedline Industries
Phase 3
Fluoride Varnish
TThe University of Hong Kong
Approved
Calcium Hydroxide
MMansoura University
Phase 2
Chlorhexidine Digluconate
GSKPreclinical
Vancomycin Hydrochloride
WWake Forest University Health Sciences
Preclinical
fluoride varnish 22600ppm
UUniversity of Peradeniya
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for fluoride varnish 22600ppm. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Company
- UUniversity of Peradeniya